Trial intelligence / Profile preview

Compartment Psoas Block in Elderly Femur Fractures

NCT04648332Completed

Start
Jan 2018
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of bupivacaine in proximal femur fracture (PFF) (3 arms). Primary endpoint: Postoperative Nalbuphine Consumption at 72 hours. Started Jan 2018; status: completed.

02

Drugs

bupivacaine
03

Conditions

proximal femur fracture (PFF)

Beyond the preview

Go deeper on NCT04648332.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04648332.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call